Interleukin-27 (IL-27) Mediates Susceptibility to Visceral Leishmaniasis by Suppressing the IL-17-Neutrophil Response

Infect Immun. 2016 Jul 21;84(8):2289-2298. doi: 10.1128/IAI.00283-16. Print 2016 Aug.

Abstract

The relationship established between Leishmania infantum and the vertebrate host can lead to a self-healing infection or to the manifestation of visceral leishmaniasis, a chronic systemic infection associated with high rates of mortality. We hypothesized that regulatory cytokines, such as interleukin-27 (IL-27), play a role in susceptibility to L. infantum infection. IL-27 is a heterodimeric cytokine composed of IL-27p28 and EBi3 subunits which, when combined, bind to IL-27R, leading to STAT-1 and -3 activation, playing a role in the regulation of the immune response. We observed in this work that IL-27 regulates the Th1/Th17 profiles in a mouse model of visceral leishmaniasis (VL) caused by L. infantum We showed here that the pathogen recognition by endosomal Toll-like receptors triggers a type I interferon (IFN) response, which acts through the type I IFN receptor and interferon regulatory factor 1 to induce IL-27 production by macrophages. Furthermore, IL-27 plays a major regulatory role in vivo, because Ebi3(-/-) mice can efficiently control parasite replication despite reduced levels of IFN-γ compared to wild-type mice. On the other hand, the absence of Ebi3 leads to exacerbated IL-17A production in the infected organs as well as in a coculture system, suggesting a direct regulatory action of IL-27 during L. infantum infection. As a consequence of exacerbated IL-17A in Ebi3(-/-) mice, a greater neutrophil influx was observed in the target organs, playing a role in parasite control. Thus, this work unveiled the molecular steps of IL-27 production after L. infantum infection and demonstrated its regulatory role in the IL-17A-neutrophil axis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cytokines / metabolism
  • Dendritic Cells / immunology
  • Dendritic Cells / metabolism
  • Disease Models, Animal
  • Disease Resistance / genetics
  • Disease Susceptibility*
  • Endosomes / metabolism
  • Interferon Type I / metabolism
  • Interleukin-17 / metabolism
  • Interleukin-27 / metabolism*
  • Leishmania infantum / immunology
  • Leishmaniasis, Visceral / immunology*
  • Leishmaniasis, Visceral / metabolism*
  • Macrophages / immunology
  • Macrophages / metabolism
  • Mice
  • Mice, Knockout
  • Neutrophils / immunology*
  • Neutrophils / metabolism*
  • Signal Transduction
  • Th17 Cells / immunology
  • Th17 Cells / metabolism
  • Toll-Like Receptors / metabolism

Substances

  • Cytokines
  • Interferon Type I
  • Interleukin-17
  • Interleukin-27
  • Toll-Like Receptors

Grants and funding

The research leading to these results received funding from the São Paulo Research Foundation (FAPESP) under grant agreement no. 2013/08216-2 (Center for Research in Inflammatory Disease) and grant 2012/14524-9, as well as from the University of São Paulo NAP-DIN under grant agreement no. 11.1.21625.01.0. G.F.S.Q. and M.S.L.N. received scholarships from FAPESP. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.